Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer
Bristol-Myers Squibb
Mark M Awad; Patrick M Forde; Nicolas Girard; Jonathan Spicer; Changli Wang; Shun Lu; Tetsuya Mitsudomi; Enriqueta Felip; Stephen R Broderick; Scott J Swanson; Julie Brahmer; Keith Kerr; Gene B Saylors; Ke-Neng Chen; Vishwanath Gharpure; Jaclyn Neely; David Balli; Nan Hu; Mariano Provencio Pulla